Your browser doesn't support javascript.
loading
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
Neoptolemos, John P; Palmer, Daniel H; Ghaneh, Paula; Psarelli, Eftychia E; Valle, Juan W; Halloran, Christopher M; Faluyi, Olusola; O'Reilly, Derek A; Cunningham, David; Wadsley, Jonathan; Darby, Suzanne; Meyer, Tim; Gillmore, Roopinder; Anthoney, Alan; Lind, Pehr; Glimelius, Bengt; Falk, Stephen; Izbicki, Jakob R; Middleton, Gary William; Cummins, Sebastian; Ross, Paul J; Wasan, Harpreet; McDonald, Alec; Crosby, Tom; Ma, Yuk Ting; Patel, Kinnari; Sherriff, David; Soomal, Rubin; Borg, David; Sothi, Sharmila; Hammel, Pascal; Hackert, Thilo; Jackson, Richard; Büchler, Markus W.
Afiliação
  • Neoptolemos JP; University of Liverpool, Liverpool, UK; The Royal Liverpool University Hospital, Liverpool, UK. Electronic address: j.p.neoptolemos@liverpool.ac.uk.
  • Palmer DH; University of Liverpool, Liverpool, UK; The Clatterbridge Cancer Centre, Wirral, UK.
  • Ghaneh P; The Royal Liverpool University Hospital, Liverpool, UK.
  • Psarelli EE; University of Liverpool, Liverpool, UK.
  • Valle JW; University of Manchester/The Christie NHS Foundation Trust, Manchester, UK.
  • Halloran CM; University of Liverpool, Liverpool, UK; The Royal Liverpool University Hospital, Liverpool, UK.
  • Faluyi O; The Clatterbridge Cancer Centre, Wirral, UK.
  • O'Reilly DA; Manchester Royal Infirmary, Manchester, UK.
  • Cunningham D; Royal Marsden Hospital, London, UK.
  • Wadsley J; Weston Park Hospital, Sheffield, UK.
  • Darby S; Weston Park Hospital, Sheffield, UK.
  • Meyer T; Royal Free Hospital, London, UK.
  • Gillmore R; Royal Free Hospital, London, UK.
  • Anthoney A; St James's University Hospital, Leeds, UK.
  • Lind P; Karolinska Institute, Stockholm, Sweden; Clinical Research Sörmland, Eskilstuna, Sweden.
  • Glimelius B; University of Uppsala, Uppsala, Sweden.
  • Falk S; Bristol Haematology and Oncology Centre, Bristol, UK.
  • Izbicki JR; University of Hamburg Medical institutions UKE, Hamburg, Germany.
  • Middleton GW; Royal Surrey County Hospital, Guildford, UK.
  • Cummins S; Royal Surrey County Hospital, Guildford, UK.
  • Ross PJ; Guy's Hospital, London, UK.
  • Wasan H; Hammersmith Hospital, London, UK.
  • McDonald A; The Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Crosby T; Velindre Hospital, Cardiff, UK.
  • Ma YT; Queen Elizabeth Hospital, Birmingham, UK.
  • Patel K; Churchill Hospital, Oxford, UK.
  • Sherriff D; Derriford Hospital, Plymouth, UK.
  • Soomal R; Ipswich Hospital, Ipswich, UK.
  • Borg D; Skåne University Hospital, Lund, Sweden.
  • Sothi S; University Hospital Coventry, Coventry, UK.
  • Hammel P; Hôpital Beaujon, Clichy, France.
  • Hackert T; University of Heidelberg, Germany.
  • Jackson R; University of Liverpool, Liverpool, UK.
  • Büchler MW; University of Heidelberg, Germany.
Lancet ; 389(10073): 1011-1024, 2017 03 11.
Article em En | MEDLINE | ID: mdl-28129987
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal Pancreático / Desoxicitidina / Capecitabina / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Ductal Pancreático / Desoxicitidina / Capecitabina / Antimetabólitos Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article